Trial Profile
Characterisation of maximum lesion count during treatment (Lmax) by non-invasive study with high definition optical coherence tomography (HD-OCT) and reflectance confocal microscopy (RCM)
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 24 Jul 2014
Price :
$35
*
At a glance
- Drugs Imiquimod (Primary)
- Indications Actinic keratosis
- Focus Diagnostic use
- 24 Jul 2014 New trial record